A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa – the transmission of COVID-19 in crowded environments (TRACE) study

DOI record: { "DOI": "10.1186/s12889-024-19462-1", "ISSN": [ "1471-2458" ], "URL": "http://dx.doi.org/10.1186/s12889-024-19462-1", "abstract": "<jats:title>Abstract</jats:title><jats:sec>\n <jats:title>Background</jats:title>\n <jats:p>South Africa’s first SARS-CoV-2 case was identified 5th March 2020 and national lockdown followed March 26th. Households are an important location for secondary SARS-CoV-2 infection. Physical distancing and sanitation – infection mitigation recommended by the World Health Organization (WHO) at the time – are difficult to implement in limited-resource settings because of overcrowded living conditions.</jats:p>\n </jats:sec><jats:sec>\n <jats:title>Methods</jats:title>\n <jats:p>This study (ClinicalTrials.gov NCT05119348) was conducted from August 2020 to September 2021 in two densely populated, low socioeconomic Cape Town community sub-districts. New COVID-19 index cases (ICs) identified at public clinics were randomised to an infection mitigation intervention (STOPCOV) delivered by lay community health workers (CHWs) or standard of care group. STOPCOV mitigation measures included one initial household assessment conducted by a CHW in which face masks, sanitiser, bleach and written information on managing and preventing spread were provided. This was followed by regular telephonic follow-up from CHWs. SARS-CoV-2 PCR and IgM/IgG serology was performed at baseline, weeks 1, 2, 3 and 4 of follow-up.</jats:p>\n </jats:sec><jats:sec>\n <jats:title>Results</jats:title>\n <jats:p>The study randomised 81 ICs with 245 HHCs. At baseline, no HHCs in the control and 7 (5%) in the intervention group had prevalent SARS-CoV-2. The secondary infection rate (SIR) based on SARS-CoV-2 PCR testing was 1.9% (<jats:italic>n</jats:italic> = 2) in control and 2.9% (<jats:italic>n</jats:italic> = 4) in intervention HHCs (<jats:italic>p</jats:italic> = 0.598). At baseline, SARS-CoV-2 antibodies were present in 15% (16/108) of control and 38% (52/137) of intervention participants. At study end incidence was 8.3% (9/108) and 8.03% (11/137) in the intervention and control groups respectively. Antibodies were present in 23% (25/108) of control HHCs over the course of the study vs. 46% (63/137) in the intervention arm. CHWs made twelve clinic and 47 food parcel referrals for individuals in intervention households in need.</jats:p>\n </jats:sec><jats:sec>\n <jats:title>Discussion</jats:title>\n <jats:p>Participants had significant exposure to SARS-CoV-2 infections prior to the study. In this setting, household transmission mitigation was ineffective. However, CHWs may have facilitated other important healthcare and social referrals.</jats:p>\n </jats:sec>", "alternative-id": [ "19462" ], "article-number": "1924", "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "6 September 2023" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "12 July 2024" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "17 July 2024" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Ethics approval and consent to participate", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The study was reviewed and approved by the University of Cape Town Human Research Ethics Committee (reference HREC ref 284/2020). Participants were informed about the study and written informed consent was obtained prior to enrolment in the study. Research was conducted in accordance with the Declaration of Helsinki." }, { "group": { "label": "Consent for publication", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "Not applicable." }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 4, "value": "The authors declare no competing interests." } ], "author": [ { "affiliation": [], "family": "Smith", "given": "Philip", "sequence": "first" }, { "affiliation": [], "family": "Little", "given": "Francesca", "sequence": "additional" }, { "affiliation": [], "family": "Hermans", "given": "Sabine", "sequence": "additional" }, { "affiliation": [], "family": "Davies", "given": "Mary-Ann", "sequence": "additional" }, { "affiliation": [], "family": "Wood", "given": "Robin", "sequence": "additional" }, { "affiliation": [], "family": "Orrell", "given": "Catherine", "sequence": "additional" }, { "affiliation": [], "family": "Pike", "given": "Carey", "sequence": "additional" }, { "affiliation": [], "family": "Peters", "given": "Fatima", "sequence": "additional" }, { "affiliation": [], "family": "Dube", "given": "Audry", "sequence": "additional" }, { "affiliation": [], "family": "Georgeu-Pepper", "given": "Daniella", "sequence": "additional" }, { "affiliation": [], "family": "Curran", "given": "Robyn", "sequence": "additional" }, { "affiliation": [], "family": "Fairall", "given": "Lara", "sequence": "additional" }, { "affiliation": [], "family": "Bekker", "given": "Linda-Gail", "sequence": "additional" } ], "container-title": "BMC Public Health", "container-title-short": "BMC Public Health", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2024, 7, 17 ] ], "date-time": "2024-07-17T18:02:39Z", "timestamp": 1721239359000 }, "deposited": { "date-parts": [ [ 2024, 7, 17 ] ], "date-time": "2024-07-17T18:03:00Z", "timestamp": 1721239380000 }, "funder": [ { "DOI": "10.13039/501100001713", "award": [ "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100001713", "id-type": "DOI" } ], "name": "European and Developing Countries Clinical Trials Partnership" }, { "DOI": "10.13039/501100000265", "award": [ "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981", "RIA2020EF-2981" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100000265", "id-type": "DOI" } ], "name": "Medical Research Council" } ], "indexed": { "date-parts": [ [ 2025, 2, 21 ] ], "date-time": "2025-02-21T10:50:24Z", "timestamp": 1740135024999, "version": "3.37.3" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2024, 7, 17 ] ] }, "journal-issue": { "issue": "1", "published-online": { "date-parts": [ [ 2024, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 7, 17 ] ], "date-time": "2024-07-17T00:00:00Z", "timestamp": 1721174400000 } }, { "URL": "https://creativecommons.org/licenses/by/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 7, 17 ] ], "date-time": "2024-07-17T00:00:00Z", "timestamp": 1721174400000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1186/s12889-024-19462-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1186/s12889-024-19462-1/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1186/s12889-024-19462-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.1186", "published": { "date-parts": [ [ 2024, 7, 17 ] ] }, "published-online": { "date-parts": [ [ 2024, 7, 17 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "author": "N Stiegler", "first-page": "695", "issue": "7", "journal-title": "Ann Méd-Psychol Rev Psychiatr", "key": "19462_CR1", "unstructured": "Stiegler N, Bouchard JP. South Africa: challenges and successes of the COVID-19 lockdown. Ann Méd-Psychol Rev Psychiatr. 2020;178(7):695–8.", "volume": "178", "year": "2020" }, { "DOI": "10.1017/dmp.2021.61", "doi-asserted-by": "crossref", "key": "19462_CR2", "unstructured": "Hatefi S, Smith F, Abou-El-Hossein K, Alizargar J. The pandemic of COVID-19: current Situation in South Africa. Disaster Med Public Health Prep. 2021;1–2." }, { "DOI": "10.1155/2020/5379278", "author": "F Nyabadza", "doi-asserted-by": "publisher", "first-page": "e5379278", "journal-title": "Comput Math Methods Med", "key": "19462_CR3", "unstructured": "Nyabadza F, Chirove F, Chukwu CW, Visaya MV. Modelling the potential impact of Social distancing on the COVID-19 epidemic in South Africa. Comput Math Methods Med. 2020;2020:e5379278.", "volume": "2020", "year": "2020" }, { "DOI": "10.7196/SAMJ.2020.v110i9.14934", "author": "AE Obasa", "doi-asserted-by": "publisher", "first-page": "858", "issue": "9", "journal-title": "S Afr Med J", "key": "19462_CR4", "unstructured": "Obasa AE, Singh S, Chivunze E, Burgess T, Masiye F, Mtande T, et al. Comparative strategic approaches to COVID-19 in Africa: balancing public interest with civil liberties. S Afr Med J. 2020;110(9):858–63.", "volume": "110", "year": "2020" }, { "DOI": "10.1093/aje/kwr251", "author": "SP Johnstone-Robertson", "doi-asserted-by": "publisher", "first-page": "1246", "issue": "11", "journal-title": "Am J Epidemiol", "key": "19462_CR5", "unstructured": "Johnstone-Robertson SP, Mark D, Morrow C, Middelkoop K, Chiswell M, Aquino LDH, et al. Social mixing patterns within a South African Township Community: implications for respiratory disease transmission and control. Am J Epidemiol. 2011;174(11):1246–55.", "volume": "174", "year": "2011" }, { "DOI": "10.1177/0956247820970094", "author": "J De Groot", "doi-asserted-by": "publisher", "first-page": "255", "issue": "1", "journal-title": "Environ Urban", "key": "19462_CR6", "unstructured": "De Groot J, Lemanski C. COVID-19 responses: infrastructure inequality and privileged capacity to transform everyday life in South Africa. Environ Urban. 2021;33(1):255–72.", "volume": "33", "year": "2021" }, { "DOI": "10.1007/s10461-020-02861-x", "doi-asserted-by": "crossref", "key": "19462_CR7", "unstructured": "Joseph Davey D, Bekker LG, Coates TJ, Myer L. Contracting HIV or contracting SAR-CoV-2 (COVID- 19) in pregnancy? Balancing the risks and benefits. AIDS Behav. 2020;1–3." }, { "DOI": "10.7196/SAMJ.2017.v107i12.12458", "author": "P Groenewald", "doi-asserted-by": "publisher", "first-page": "1091", "issue": "12", "journal-title": "S Afr Med J", "key": "19462_CR8", "unstructured": "Groenewald P, Neethling I, Evans J, Azevedo V, Naledi T, Matzopoulos R, et al. Mortality trends in the City of Cape Town between 2001 and 2013: reducing inequities in health. S Afr Med J. 2017;107(12):1091–8.", "volume": "107", "year": "2017" }, { "key": "19462_CR9", "unstructured": "Statistics South Africa. 2011 Census products | Statistics South Africa [Internet]. 2011 [cited 2017 Dec 20]. http://www.statssa.gov.za/?page_id=3955." }, { "DOI": "10.1016/S2214-109X(21)00289-8", "author": "W Jassat", "doi-asserted-by": "publisher", "first-page": "e1216", "issue": "9", "journal-title": "Lancet Glob Health", "key": "19462_CR10", "unstructured": "Jassat W, Mudara C, Ozougwu L, Tempia S, Blumberg L, Davies MA, et al. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health. 2021;9(9):e1216–25.", "volume": "9", "year": "2021" }, { "author": "K Moodley", "first-page": "554", "issue": "6", "journal-title": "S Afr Med J", "key": "19462_CR11", "unstructured": "Moodley K, Blockman M, Pienaar D, Hawkridge AJ, Meintjes J, Davies MA, et al. Hard choices: ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa. S Afr Med J. 2021;111(6):554–8.", "volume": "111", "year": "2021" }, { "key": "19462_CR12", "unstructured": "NICD. COVID-19 Weekly Epidemiological Brief [Internet]. NICD. 2022 [cited 2023 Jun 5]. https://www.nicd.ac.za/wp-content/uploads/2022/04/COVID-19-Weekly-Epidemiology-Brief-week-15-2022.pdf." }, { "DOI": "10.1016/j.psychres.2019.112630", "author": "SJ Landes", "doi-asserted-by": "publisher", "first-page": "112630", "journal-title": "Psychiatry Res", "key": "19462_CR13", "unstructured": "Landes SJ, McBain SA, Curran GM. Reprint of: an introduction to effectiveness-implementation hybrid designs. Psychiatry Res. 2020;283:112630.", "volume": "283", "year": "2020" }, { "DOI": "10.4085/1062-6050-43.2.215", "author": "M Kang", "doi-asserted-by": "publisher", "first-page": "215", "issue": "2", "journal-title": "J Athl Train", "key": "19462_CR14", "unstructured": "Kang M, Ragan BG, Park JH. Issues in Outcomes Research: an overview of randomization techniques for clinical trials. J Athl Train. 2008;43(2):215–21.", "volume": "43", "year": "2008" }, { "DOI": "10.1371/journal.pone.0000012", "author": "D Klinkenberg", "doi-asserted-by": "publisher", "first-page": "e12", "issue": "1", "journal-title": "PLoS ONE", "key": "19462_CR15", "unstructured": "Klinkenberg D, Fraser C, Heesterbeek H. The effectiveness of contact tracing in emerging epidemics. PLoS ONE. 2006;1(1):e12.", "volume": "1", "year": "2006" }, { "DOI": "10.21203/rs.3.rs-233375/v1", "doi-asserted-by": "crossref", "key": "19462_CR16", "unstructured": "Sykes W, Mhlanga L, Swanevelder R, Glatt TN, Grebe E, Coleman C et al. Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Res Sq [Internet]. 2021 Feb 12 [cited 2021 Apr 16]; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885925/." }, { "key": "19462_CR17", "unstructured": "Hsiao M, Davies MA, Kalk E, Hardie D, Naidoo M, Centner C et al. SARS-COV-2 Seroprevalence In The Cape Town Metropolitan Sub-Districts After The Peak Of Infections [Internet]. 2020 [cited 2021 Apr 16]. https://scholar.google.com/scholar_lookup?journal=NICD+COVID-19+Special+Public+Health+Surveill+Bull&title=SARS-CoV-2+seroprevalence+in+the+Cape+Town+Metropolitan+sub-districts+after+the+peak+of+infections&author=M+Hsiao&author=MA+Davies&author=E+Kalk&volume=18&publication_year=2020&pages=1-9&." }, { "DOI": "10.1111/tmi.13752", "author": "MA Davies", "doi-asserted-by": "publisher", "first-page": "564", "issue": "6", "journal-title": "Trop Med Int Health", "key": "19462_CR18", "unstructured": "Davies MA, Kassanjee R, Rousseau P, Morden E, Johnson L, Solomon W, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop Med Int Health. 2022;27(6):564–73.", "volume": "27", "year": "2022" }, { "DOI": "10.4110/in.2021.21.e9", "author": "S Bae", "doi-asserted-by": "publisher", "first-page": "e9", "issue": "1", "journal-title": "Immune Netw", "key": "19462_CR19", "unstructured": "Bae S, Lim JS, Kim JY, Jung J, Kim SH. Transmission characteristics of SARS-CoV-2 that Hinder Effective Control. Immune Netw. 2021;21(1):e9.", "volume": "21", "year": "2021" }, { "DOI": "10.1371/journal.pone.0240205", "author": "WC Koh", "doi-asserted-by": "publisher", "first-page": "e0240205", "issue": "10", "journal-title": "PLoS ONE", "key": "19462_CR20", "unstructured": "Koh WC, Naing L, Chaw L, Rosledzana MA, Alikhan MF, Jamaludin SA, et al. What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS ONE. 2020;15(10):e0240205.", "volume": "15", "year": "2020" }, { "DOI": "10.1093/cid/ciab100", "doi-asserted-by": "publisher", "key": "19462_CR21", "unstructured": "Thompson HA, Mousa A, Dighe A, Fu H, Arnedo-Pena A, Barrett P et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis. Clin Infect Dis [Internet]. 2021 Feb 9 [cited 2021 Apr 16];(ciab100). https://doi.org/10.1093/cid/ciab100." }, { "author": "G Maimela", "first-page": "64", "issue": "2", "journal-title": "SAMJ South Afr Med J", "key": "19462_CR22", "unstructured": "Maimela G, Martin CE, Chersich M, Bello B, Mauti J, Barnighausen T, et al. Household transmission of SARS-CoV-2 in a rural area in South Africa. SAMJ South Afr Med J. 2024;114(2):64–71.", "volume": "114", "year": "2024" }, { "DOI": "10.1016/S1473-3099(22)00069-X", "author": "C Cohen", "doi-asserted-by": "publisher", "first-page": "821", "issue": "6", "journal-title": "Lancet Infect Dis", "key": "19462_CR23", "unstructured": "Cohen C, Kleynhans J, von Gottberg A, McMorrow ML, Wolter N, Bhiman JN, et al. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. Lancet Infect Dis. 2022;22(6):821–34.", "volume": "22", "year": "2022" }, { "DOI": "10.1016/S2468-2667(20)30157-2", "author": "ME Kretzschmar", "doi-asserted-by": "publisher", "first-page": "e452", "issue": "8", "journal-title": "Lancet Public Health", "key": "19462_CR24", "unstructured": "Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Public Health. 2020;5(8):e452–9.", "volume": "5", "year": "2020" }, { "DOI": "10.1016/S2468-2667(22)00001-9", "author": "AD Hossain", "doi-asserted-by": "publisher", "first-page": "e259", "issue": "3", "journal-title": "Lancet Public Health", "key": "19462_CR25", "unstructured": "Hossain AD, Jarolimova J, Elnaiem A, Huang CX, Richterman A, Ivers LC. Effectiveness of contact tracing in the control of infectious diseases: a systematic review. Lancet Public Health. 2022;7(3):e259–73.", "volume": "7", "year": "2022" }, { "DOI": "10.1016/j.epidem.2020.100428", "author": "D Lunz", "doi-asserted-by": "publisher", "first-page": "100428", "journal-title": "Epidemics", "key": "19462_CR26", "unstructured": "Lunz D, Batt G, Ruess J. To quarantine, or not to quarantine: a theoretical framework for disease control via contact tracing. Epidemics. 2021;34:100428.", "volume": "34", "year": "2021" }, { "DOI": "10.2196/26073", "author": "G Harling", "doi-asserted-by": "publisher", "first-page": "e26073", "issue": "5", "journal-title": "JMIR Public Health Surveill", "key": "19462_CR27", "unstructured": "Harling G, Gómez-Olivé FX, Tlouyamma J, Mutevedzi T, Kabudula CW, Mahlako R, et al. Protective behaviors and secondary Harms resulting from nonpharmaceutical interventions during the COVID-19 epidemic in South Africa: Multisite, prospective longitudinal study. JMIR Public Health Surveill. 2021;7(5):e26073.", "volume": "7", "year": "2021" }, { "DOI": "10.7196/SAMJ.2021.v111i8.15786", "author": "Y Pillay", "doi-asserted-by": "publisher", "first-page": "714", "issue": "8", "journal-title": "S Afr Med J", "key": "19462_CR28", "unstructured": "Pillay Y, Pienaar S, Barron P, Zondi T. Impact of COVID-19 on routine primary healthcare services in South Africa. S Afr Med J. 2021;111(8):714–9.", "volume": "111", "year": "2021" }, { "DOI": "10.2105/AJPH.2022.306842", "author": "WM El-Sadr", "doi-asserted-by": "publisher", "first-page": "1025", "issue": "7", "journal-title": "Am J Public Health", "key": "19462_CR29", "unstructured": "El-Sadr WM, Platt J, Bernitz M, Reyes M. Contact tracing: barriers and facilitators. Am J Public Health. 2022;112(7):1025–33.", "volume": "112", "year": "2022" }, { "DOI": "10.1371/journal.pone.0276661", "author": "L Dowthwaite", "doi-asserted-by": "publisher", "first-page": "e0276661", "issue": "10", "journal-title": "PLoS ONE", "key": "19462_CR30", "unstructured": "Dowthwaite L, Wagner HG, Babbage CM, Fischer JE, Barnard P, Nichele E, et al. The relationship between trust and attitudes towards the COVID-19 digital contact-tracing app in the UK. PLoS ONE. 2022;17(10):e0276661.", "volume": "17", "year": "2022" }, { "DOI": "10.1371/journal.pone.0251033", "author": "T Shelby", "doi-asserted-by": "publisher", "first-page": "e0251033", "issue": "5", "journal-title": "PLoS ONE", "key": "19462_CR31", "unstructured": "Shelby T, Hennein R, Schenck C, Clark K, Meyer AJ, Goodwin J, et al. Implementation of a volunteer contact tracing program for COVID-19 in the United States: a qualitative focus group study. PLoS ONE. 2021;16(5):e0251033.", "volume": "16", "year": "2021" }, { "author": "K Vallabhjee", "first-page": "173", "issue": "1", "journal-title": "South Afr Health Rev", "key": "19462_CR32", "unstructured": "Vallabhjee K, Gilson L, Davies MA, Boulle A, Pienaar D, Reagon G, et al. Reflections on the health system response to COVID-19 in the Western Cape Province. South Afr Health Rev. 2021;2021(1):173–87.", "volume": "2021", "year": "2021" } ], "reference-count": 32, "references-count": 32, "relation": {}, "resource": { "primary": { "URL": "https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-19462-1" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa – the transmission of COVID-19 in crowded environments (TRACE) study", "type": "journal-article", "update-policy": "https://doi.org/10.1007/springer_crossmark_policy", "volume": "24" }